These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 16085332)
21. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation. Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699 [TBL] [Abstract][Full Text] [Related]
22. Effect of Si and Fe doping on calcium phosphate glass fibre reinforced polycaprolactone bone analogous composites. Mohammadi MS; Ahmed I; Muja N; Almeida S; Rudd CD; Bureau MN; Nazhat SN Acta Biomater; 2012 Apr; 8(4):1616-26. PubMed ID: 22248526 [TBL] [Abstract][Full Text] [Related]
23. Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies. Ni S; Lin K; Chang J; Chou L J Biomed Mater Res A; 2008 Apr; 85(1):72-82. PubMed ID: 17688291 [TBL] [Abstract][Full Text] [Related]
24. Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass. Li H; Du R; Chang J J Biomater Appl; 2005 Oct; 20(2):137-55. PubMed ID: 16183674 [TBL] [Abstract][Full Text] [Related]
25. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it]. Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451 [TBL] [Abstract][Full Text] [Related]
26. Polycaprolactone-20% tricalcium phosphate scaffolds in combination with platelet-rich plasma for the treatment of critical-sized defects of the mandible: a pilot study. Rai B; Ho KH; Lei Y; Si-Hoe KM; Jeremy Teo CM; Yacob KB; Chen F; Ng FC; Teoh SH J Oral Maxillofac Surg; 2007 Nov; 65(11):2195-205. PubMed ID: 17954314 [TBL] [Abstract][Full Text] [Related]
27. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Everts PA; Hoffmann J; Weibrich G; Mahoney CB; Schönberger JP; van Zundert A; Knape JT Transfus Med; 2006 Oct; 16(5):363-8. PubMed ID: 16999760 [TBL] [Abstract][Full Text] [Related]
28. Regulation of physicochemical properties, osteogenesis activity, and fibroblast growth factor-2 release ability of β-tricalcium phosphate for bone cement by calcium silicate. Su CC; Kao CT; Hung CJ; Chen YJ; Huang TH; Shie MY Mater Sci Eng C Mater Biol Appl; 2014 Apr; 37():156-63. PubMed ID: 24582235 [TBL] [Abstract][Full Text] [Related]
29. Counting of platelet derived growth factor and transforming growth factor-beta in platelet-rich-plasma used in jaw bone regeneration. Tonelli P; Mannelli D; Brancato L; Cinotti S; Morfini M Minerva Stomatol; 2005; 54(1-2):23-34. PubMed ID: 15902060 [TBL] [Abstract][Full Text] [Related]
30. Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells. Huang Q; Wang YD; Wu T; Jiang S; Hu YL; Pei GX Chin Med J (Engl); 2009 Jan; 122(1):83-7. PubMed ID: 19187622 [TBL] [Abstract][Full Text] [Related]
31. Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study. Kasten P; Beyen I; Niemeyer P; Luginbühl R; Bohner M; Richter W Acta Biomater; 2008 Nov; 4(6):1904-15. PubMed ID: 18571999 [TBL] [Abstract][Full Text] [Related]
32. In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF. Su CY; Kuo YP; Tseng YH; Su CH; Burnouf T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):56-61. PubMed ID: 19451002 [TBL] [Abstract][Full Text] [Related]
33. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions. Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609 [TBL] [Abstract][Full Text] [Related]
34. Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood. Zimmermann R; Loew D; Weisbach V; Strasser E; Ringwald J; Zingsem J; Eckstein R Transfusion; 2005 Mar; 45(3):414-9. PubMed ID: 15752160 [TBL] [Abstract][Full Text] [Related]
35. Casein and soybean protein-based thermoplastics and composites as alternative biodegradable polymers for biomedical applications. Vaz CM; Fossen M; van Tuil RF; de Graaf LA; Reis RL; Cunha AM J Biomed Mater Res A; 2003 Apr; 65(1):60-70. PubMed ID: 12635155 [TBL] [Abstract][Full Text] [Related]
36. Fibre reinforced bioresorbable composites for spinal surgery. Huttunen M; Ashammakhi N; Törmälä P; Kellomäki M Acta Biomater; 2006 Sep; 2(5):575-87. PubMed ID: 16807156 [TBL] [Abstract][Full Text] [Related]
37. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. Li H; Chang J J Control Release; 2005 Oct; 107(3):463-73. PubMed ID: 16154657 [TBL] [Abstract][Full Text] [Related]
38. The degradation profile of novel, bioresorbable PCL-TCP scaffolds: an in vitro and in vivo study. Yeo A; Rai B; Sju E; Cheong JJ; Teoh SH J Biomed Mater Res A; 2008 Jan; 84(1):208-18. PubMed ID: 17607768 [TBL] [Abstract][Full Text] [Related]
39. A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets. Burnouf T; Kuo YP; Huang CT; Tseng YH; Lin CT; Su CY Transfusion; 2010 Aug; 50(8):1702-11. PubMed ID: 20412527 [TBL] [Abstract][Full Text] [Related]
40. Bioactivity in in situ hydroxyapatite-polycaprolactone composites. Verma D; Katti K; Katti D J Biomed Mater Res A; 2006 Sep; 78(4):772-80. PubMed ID: 16739180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]